propafenone has been researched along with Agranulocytosis in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propafenone is an antiarrhythmic drug used in the treatment of life-threatening ventricular tachyarrhythmias." | 5.30 | Propafenone-induced drug fever in the absence of agranulocytosis. ( Gerling, BR; Greenberg, ML; Holzberger, PT; O'Rourke, DJ; Palac, RT, 1997) |
| "Propafenone hydrochloride was approved for marketing by the United States (U." | 5.28 | Propafenone associated agranulocytosis. ( Jolson, HM; Miwa, LJ, 1992) |
| "Propafenone is an antiarrhythmic drug used in the treatment of life-threatening ventricular tachyarrhythmias." | 1.30 | Propafenone-induced drug fever in the absence of agranulocytosis. ( Gerling, BR; Greenberg, ML; Holzberger, PT; O'Rourke, DJ; Palac, RT, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayrhofer, EF | 1 |
| Davogg, S | 1 |
| Feilhauer, GD | 1 |
| Pilecky, I | 1 |
| Seisenbacher, H | 1 |
| Vockner, H | 1 |
| O'Rourke, DJ | 1 |
| Palac, RT | 1 |
| Holzberger, PT | 1 |
| Gerling, BR | 1 |
| Greenberg, ML | 1 |
| Miwa, LJ | 1 |
| Jolson, HM | 1 |
3 other studies available for propafenone and Agranulocytosis
| Article | Year |
|---|---|
[Profound granulocytopenia in a patient treated with propafenon ].
Topics: Aged; Agranulocytosis; Anti-Arrhythmia Agents; Female; Humans; Myocardial Infarction; Propafenone; P | 1982 |
Propafenone-induced drug fever in the absence of agranulocytosis.
Topics: Agranulocytosis; Anti-Arrhythmia Agents; Diagnosis, Differential; Fever; Humans; Leukocyte Count; Ma | 1997 |
Propafenone associated agranulocytosis.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Female; Humans; Male; Middle Aged; Propafenone | 1992 |